Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Vioxx Withdrawal: Can the Industry Avoid the Whirlpool?

Nov 01 2004

Related Content

The Winners Post-Vioxx: Merck's Product-Focused Biotechs

Nov 01 2004

Technology Investing: One VC's View of the Value Proposition for Today's Market

Oct 01 2004

Drug Delivery's Product Risk and Reward

Oct 01 2004

Combination Drugs

Nov 01 2004

The Outlook for Pharmacogenomics Testing in Primary Care

Nov 01 2004

Related Companies

Merck & Co., Inc.

Pfizer Inc.

Boehringer Ingelheim GmbH

Novartis AG

GSK plc

Bayer AG

AstraZeneca PLC

Wyeth

Bristol Myers Squibb Company

Schering-Plough

H. Lundbeck A/S

Eli Lilly and Company

MannKind Corporation

Gilead Sciences, Inc.

Nicox S.A.

NitroMed, Inc.

Adhera Therapeutics, Inc.

Gilead Sciences, Inc.

Alnylam Pharmaceuticals Inc.

Genentech, Inc.

Amgen, Inc.

Additional Topics

Strategy Business Strategies Regulation Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.